List of Diagnostics Companies in Florida - 17

Aurita Corp is a synthetic biology startup that creates a platform for 3D bioscience intended to provide personalized medicine and diagnostics, therapeutic solutions, and cell culture tools.

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.

Cytonics is a research and development company dedicated to discovering and developing therapeutics based on the protease inhibitor Alpha2 Macroglobulin (A2M). Theyhave discovered a unique “bio-marker” that can assist physicians in improving patient outcomes by pinpointing the source of orthopedic pain. We are also developing a range of therapeutic products for the treatment of painful osteoarthritis, back, and joint pain.

Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.

Express Gene Molecular Diagnostics Laboratory is a CLIA CLIA-certified laboratory located in Miami, Florida. Our focus is genetic testing and we offer several important genetic tests, including pharmacogenomics tests. Pharmacogenetic (PGx) testing is a type of genetic test that assesses a patient's risk of an adverse response or likelihood to respond to a given drug. This gives healthcare providers insight into what medications to use for a given condition. The PGx test allows physicians to make informed, science-based drug selections and appropriately adjust the dosing.

Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibronostics'​ LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool. Fibronostics'​ HealthFACTR tool employes technology to predict risk, providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease. HealthFACTR enables action-oriented recommendations which allow healthcare professions to determine patients'​ risk levels and drive better patient care.

For patients whose cancer has returned, First Ascent Biomedical provides new ways to fight by combining functional drug testing, genomics, and artificial intelligence to design an individualized treatment plan in a week for each patient. Our technology rapidly grows tumor bulk, more importantly chemo-resistant cells enabling the testing 100s of FDA-approved drugs to measure the cellular response of both cell populations. This is the key dataset for the AI engine, supported by genomics data to identify every cancer weakness and identify which drugs work.

We are building the largest longitudinal cohort in the Americas to power precision health at scale for all. Our goal is to improve diagnostic testing and accelerate drug discovery in diverse underserved populations. We are focused on Latin America and our diaspora populations throughout the world including founder populations in the Americas, those who identify as Hispanic/Latino, Black or African American, Asian American, American Indian/Alaska Native, First Nations, and Native Hawaiian/Pacific Islander as well as people who self identify as belonging to two or more of these groups. Core to our mission is building trust with the communities we serve and long term partnerships with communities, researchers, clinicians, and most of all patients and their families. This is your biobank and for the benefit of all. If we build it, we can decide how the data are used. And no one is going to do it for us, so let’s roll up our sleeves and “time to build.” Join us! Este biobanco es tuyo y para todo el continente porque si lo construimos juntos podemos decidir cómo se usan los datos y con que fines. Nadie lo va a hacer por nosotros así que bienvenido a nuestro esfuerzo. Unete!

Molecular Diagnostics

IGENOMIX USA is a biotechnology company that specializes in genetic testing services for reproductive health and fertility.

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

Nonagen Bioscience is a biotechnology company that specializes in developing first-in-class diagnostics for early detection and prediction of human cancers.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

We Put The Needs Of Healthcare Providers At The Center Of Everything We Do. We understand the unprecedented challenges faced by providers today. We have made it our mission to create single-source solutions that help you navigate today's turbulent regulatory, medical and market environments while protecting your patients, your employees and your profitability. Our Unified Approach Is Driving New Ideas Rennova Health is reimagining the traditional channels of healthcare services with an expansive suite of diverse products and brands. These interoperable solutions work in unison to drive better treatment outcomes, more cost-effective patient care, and optimized revenue streams. We support each of our solutions with unprecedented service excellence, while continuing to build on the best medical science and technologies available. We also maintain the highest standards of corporate transparency, fiduciary responsibility, accountability, and regulatory compliance. Rennova Health encompasses an ever-expanding group of remarkable products, services and resources. By incorporating diverse brands underneath a single company, we create more empowering, efficient and innovative solutions to address your most pressing challenges, including: Industry-leading diagnostic testing solutions for precision medicine. Streamlined EHRs, a proprietary lab ordering and reporting application, and other progressive software services. Comprehensive medical billing and financial services for enhanced revenue cycle management. Rennova Health's Brands: Medytox Diagnostics Advantage ClinLab CollabRx Medical Mime Medical Billing Choices Platinum Financial Services

Read the eBook on Navigating R&D: https://www.starlims.com/navigating-research-and-development-guide/ **One partner, powerful informatics solutions.** STARLIMS is a recognized leader in enterprise laboratory informatics, providing customers around the world with digital solutions for R&D and quality labs. With nearly four decades as in informatics, STARLIMS is in the business of delivering results. 🌐 2,000+ Labs Worldwide 👥 1,100+ Customers 🌍 85+ Countries 🔬 LIMS, SDMS, LES, and Advanced Analytics 🏆 Leader on G2 💡 With the intuitive cloud Labstep Electronic Lab Notebook (ELN) STARLIMS is your one true partner in lab informatics from R&D through to commercialization 🌟 Industry Solutions: 🧪 Life Sciences 🏭 Contract Development Manufacturing Organizations (CDMOs) 🍔 Food & Beverage ⚗️ Chemical 🍃 Agrochemical ⛽ Oil & Gas 🛍️ Consumer Goods 📝 Contract Testing, 🏥 Public Health 🩺 Clinical Diagnostics We're committed to providing quality products and services that help our customers reach their goals. Whether your mission is to discover a breakthrough drug, protect the health of the population, or get safe toys to market, we're here to support you.

Verséa, is a US-based healthcare company is comprised of 4 divisions: Verséa Therapeutics, Verséa Diagnostics, Verséa Scientific Discovery & Verséa Ophthalmics. Regardless of which vertical within Verséa, our committed medical and executive team focus on transformative health solutions for patients, caregivers and healthcare professionals, delivered with care. With a combined 500+ years of expertise, the Verséa team has achieved both national and worldwide success in highly regulated markets. The Verséa team consists of experienced multidisciplinary business executives and prominent scientific medical experts in their respective fields of specialties, who collaborate to provide solutions to healthcare challenges humanity is facing today. To find out more, visit our corporate website: www.verséa.com